Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis (Cancer-DACUS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2009 by Azienda Ospedaliera Universitaria Policlinico.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Azienda Ospedaliera Universitaria Policlinico
ClinicalTrials.gov Identifier:
NCT00450645
First received: March 20, 2007
Last updated: March 3, 2009
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2011
  Estimated Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):